NCT05779163 2025-05-07
A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors
Nanjing Leads Biolabs Co.,Ltd
Phase 1/2 Recruiting
Nanjing Leads Biolabs Co.,Ltd
NovaRock Biotherapeutics, Ltd
Suzhou Suncadia Biopharmaceuticals Co., Ltd.